Abstract
The regulation of GABA release from the inhibitory input to dopamine cells in the substantia nigra pars compacta (SNc) plays a key role in different reward-related behaviors. Gamma-hydroxybutyrate (GHB) has therapeutical properties in various psychiatric disorders, especially in alcohol abuse. GHB is also used as a drug of abuse, which induces sedation and euphoria. Using whole-cell patch-clamp recordings, we studied the effects of GHB on GABA release in the SNc by recording spontaneous inhibitory postsynaptic currents (sIPSCs) in brain slices of 21- to 25-day-old rats. We found that GHB depressed the frequency and amplitude of sIPSCs, while the frequency and the amplitude of miniature inhibitory postsynaptic currents (mIPSCs), recorded in the presence of TTX, were not affected. However, in the presence of high extracellular potassium (15 mM), which increases the contribution of voltage-dependent calcium channels, GHB induced a reduction in the frequency of the mIPSCs without any effect on their amplitude. All of these effects were GABAB-independent and they were blocked by the GHB receptor antagonist NCS-382. The present results indicate that GHB inhibits spontaneous inhibitory synaptic transmission recorded from dopaminergic neurons in the SNc likely by reducing voltage-dependent calcium influx involved in presynaptic GABA release.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Addolorato G, Cibin M, Caprista E, Beghe F, Gessa GL, Stefanini GF et al (1998). Maintaining abstinence from alcohol with gamma-hydroxybutyric acid. Lancet 351: 38.
Banerjee PK, Snead OC (1995). Presynaptic gamma-hydroxybutyric acid and gamma-aminobutyric acid B receptor-mediated release of GABA and glutamate in rat thalamic ventrobasal nucleus: a possible mechanism for the generation of absence-like seizures induced by gamma-hydroxybutyric acid. J Pharmacol Exp Ther 273: 1534–1543.
Benavides J, Rumigny JF, Bourguignon JJ, Cash C, Wermuth CG, Mandel P et al (1982). High affinity binding sites for gamma-hydroxybutyric acid in rat brain. Life Sci 30: 953–961.
Bernasconi R, Mathivet P, Marescaux C (1999). Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential? Trends Pharmacol Sci 20: 135–141.
Berton F, Brancucci A, Beghè F, Cammalleri M, Demuro A, Francesconi W et al (1999). Gamma-hydroxybutyrate inhibits excitatory postsynaptic potentials in rat hippocampal slices. Eur J Pharmacol 380: 109–116.
Bessman SP, Fishbein WN (1963). Gamma-hydroxybutyrate, a normal brain metabolite. Nature 200: 1207–1208.
Bolam JP, Smith Y (1990). The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat. Brain Res 529: 57–78.
Bunney BS, Chiodo LA, Grace AA (1991). Midbrain dopamine system electrophysiological functioning: a review and new hypothesis. Synapse 9: 79–94; (review).
Cammalleri M, Brancucci A, Berton F, Locche A, Gessa GL, Francesconi W (2002). Gamma-hydroxybutyric acid reduces GABA-mediated inhibitory postsynaptic potentials in the CA1 region of hippocampus. Neuropsychopharmacology 27: 960–969.
Carter LP, Flores LR, Wu H, Chen W, Unzeitig AW, Coop A et al (2003). The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. J Pharmacol Exp Ther 305: 668–674.
Castelli MP, Mocci I, Langlois X, Gommerendagger W, Luyten WH, Leysen JE et al (2000). Quantitative autoradiographic distribution of gamma-hydroxybutyric acid binding sites in human and monkey brain. Brain Res Mol Brain Res 78: 91–99.
Chen BT, Rice ME (2002). Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area. J Neurochem 81: 158–169.
Diana M, Mereu G, Mura A, Fadda F, Passino N, Gessa G (1991). Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Res 566: 208–211.
Erhardt S, Andersson B, Nissbrandt H, Engberg G (1998). Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors. Naunyn Schmiedebergs Arch Pharmacol 357: 611–619.
Fadda F, Mosca GL, Colombo G, Gessa GL (1988). Gamma-hydroxybutyric acid suppresses ethanol consumption in alcohol-preferring rats. Psychopharmacology 96(Suppl.): 107.
Fasano S, Brambilla R (2002). Cellular mechanisms of striatum-dependent behavioral plasticity and drug addiction. Curr Mol Med 2: 649–665.
Galloway GP, Frederick SL, Staggers Jr FE, Gonzalez M, Stalcup A, Smith DE (1997). Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction 92: 89–96.
Gould GG, Mehta AK, Frazer A, Ticku MK (2003). Quantitative autoradiographic analysis of the new radioligand [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid ([(3)H]NCS-382) at gamma-hydroxybutyric acid (GHB) binding sites in rat brain. Brain Res 979: 51–56.
Grace AA, Bunney BS (1983). Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization. Neuroscience 10: 301–315.
Hausser MA, Yung WH (1994). Inhibitory synaptic potentials in guinea-pig substantia nigra dopamine neurones in vitro. J Physiol 479: 401–422.
Hechler V, Gobaille S, Bourguignon JJ, Maitre M (1991). Extracellular events induced by gamma-hydroxybutyrate in striatum: a microdialysis study. J Neurochem 56: 938–944.
Hechler V, Gobaille S, Maitre M (1992). Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res 572: 345–348.
Hechler V, Weissmann D, Mach E, Pujol JF, Maitre M (1987). Regional distribution of high-affinity gamma-[3H]hydroxybutyrate binding sites as determined by quantitative autoradiography. J Neurochem 49: 1025–1032.
Hedou G, Chasserot-Golaz S, Kemmel V, Gobaille S, Roussel G, Artault JC et al (2000). Immunohistochemical studies of the localization of neurons containing the enzyme that synthesizes dopamine, GABA, or gammahydroxybutyrate in the rat substantia nigra and striatum. J Comp Neurol 426: 549–560.
Hu RQ, Banerjee PK, Snead III OC (2000). Regulation of gamma-aminobutyric acid release in cerebral cortex in the gamma-hydroxybutyric acid model of absence seizures in rat. Neuropharmacology 39: 427–439.
Hyman SE, Malenka RC (2001). Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2: 695–703; (review).
Jensen K, Mody I (2001). GHB depresses fast excitatory and inhibitory synaptic transmission via GABAB receptors in mouse neocortical neurons. Cerebral Cortex 11: 424–429.
King MA, Thinschmidt JS, Walker DW (1997). Gamma-hydroxybutyrate receptor ligand effects on evoked synaptic field potentials in CA1 of the rat hippocampal slice. J Neural Transm 104: 1177–1193.
Kleinschmidt S, Scellhase C, Martzluft F (1999). Continous sedation during spinal anaesthesia: gamma-hydroxybutyrate vs propofol. Eur J Anaesthesiol 16: 23–30.
Kozhechkin SX (1980). Microiontophoretic study of the mechanism of action of gamma-hydroxybutyric acid. Bull Exp Biol Med 88: 1293–1296.
Lamb RJ, Munn J, Duiker NJ, Coop A, Wu H, Koek W et al (2003). Interactions of gamma-hydroxybutyrate with ethanol and NCS 382. Eur J Pharmacol 470: 157–162.
Madden TE, Johnson SW (1998). Gamma-hydroxybutyrate is a GABAB receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons. J Pharmacol Exp Ther 287: 261–265.
Maharajan P, Maharajan V, Ravagnan G, Paino G (2001). The weaver mutant mouse: a model to study the ontogeny of dopamine transmission systems and their role in drug addiction. Prog Neurobiol 64: 269–276; (review).
Maitre M (1997). The gamma-hydroxybutyrate signalling system in the brain: organization and functional implications. Prog Neurobiol 51: 337–361.
Maitre M, Hechler V, Vayer P, Gobaille S, Cash CD, Schmitt M et al (1990). A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J Pharmacol Exp Ther 255: 657–663.
Maitre M, Rumigny JF, Cash C, Mandel P (1983). Subcellular distribution of gamma-hydroxybutyrate binding sites in rat brain. Principal location in the synaptosomal fraction. Biochem Biophys Res Commun 110: 262–265.
Mamelak M, Scharf MB, Woods M (1986). Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 9: 285–289.
Mercuri NB, Bonci A, Calabresi P, Stratta F, Bernardi G (1995). Properties of the hyperpolarization-activated cation current Ih in rat midbrain dopaminergic neurons. Eur J Neurosci 7: 462–469.
Metcalf BR, Stahl JM, Allen JD, Woolfolk DR, Soto PL (2001). Discrimination of gamma-hydroxybutyrate and ethanol administered separately and as a mixture in rats. Pharmacol Biochem Behav 70: 31–41.
Nissbrandt H, Elverfors A, Engberg G (1994). Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux. Synapse 17: 217–224.
Olpe HR, Koella WP (1979). Inhibition of nigral and neocortical cells by gamma-hydroxybutyrate: a microiontophoretic investigation. Eur J Pharmacol 53: 359–364.
Paladini CA, Celada P, Tepper JM (1999). Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo. Neuroscience 89: 799–812.
Poldrugo F, Addolorato G (1999). The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies. Alcohol Alcohol 34: 15–24.
Roth RH, Giarman NJ (1969). Conversion of gamma-aminobutyric acid to gamma-hydroxybutyric acid in the rat. Biochem Pharmacol 19: 3001–3012.
Shepard PD, Connelly ST (1999). Pertussis toxin lesions of the rat substantia nigra block the inhibitory effects of the gamma-hydroxybutyrate agent, S(-)HA-966 without affecting the basal firing properties of dopamine neurons. Neuropsychopharmacology 21: 650–661.
Smith AD, Bolam JP (1990). The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 13: 259–265; (review).
Smith Y, Charara A, Parent A (1996). Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey. J Comp Neurol 364: 231–253.
Snead III OC (2000). Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor. J Neurochem 75: 1986–1996.
Somogyi P, Bolam JP, Totterdell S, Smith AD (1981). Monosynaptic input from the nucleus accumbens—ventral striatum region to retrogradely labelled nigrostriatal neurones. Brain Res 217: 245–263.
Xie X, Smart TG (1992a). Gamma-hydroxybutyrate hyperpolarizes hippocampal neurons by activating GABAB receptors. Eur J Pharmacol 212: 291–294.
Xie X, Smart TG (1992b). Gamma-hydroxybutyrate depresses monosynaptic excitatory and inhibitory postsynaptic potentials in rat hippocampal slices. Eur J Pharmacol 223: 193–196.
Acknowledgements
We thank P Schweitzer for critical comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brancucci, A., Berretta, N., Mercuri, N. et al. Presynaptic Modulation of Spontaneous Inhibitory Postsynaptic Currents by Gamma-hydroxybutyrate in the Substantia Nigra Pars Compacta. Neuropsychopharmacol 29, 537–543 (2004). https://doi.org/10.1038/sj.npp.1300344
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300344
Keywords
This article is cited by
-
Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (γ‐hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1−/− mice and characterization of γ‐hydroxybutyric acid pharmacology
Journal of Inherited Metabolic Disease (2007)
